Ergoteles LLC Care Dx, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $77,637 - $96,510	10,202 New	10,202 $86,000
Q2 2022 Aug 12, 2022	SELL	$20.49 - $39.72 $599,127 - $1.16 Million	-29,240 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $824,275 - $1.36 Million	29,240 New	29,240 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $348,985 - $542,741	-5,900 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$63.02 - $95.11 $371,818 - $561,149	5,900 New	5,900 $540,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.